Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Guideline Alignment in Related Areas.

Dubrofsky L, Tobe SW.

Can J Cardiol. 2019 May;35(5):606-610. doi: 10.1016/j.cjca.2019.01.001. Epub 2019 Jan 10. Review.

PMID:
31030862
2.

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, Sarnak MJ, Tobe SW, Tomson CRV, Cheung M, Wheeler DC, Winkelmayer WC, Mann JFE; Conference Participants.

Kidney Int. 2019 May;95(5):1027-1036. doi: 10.1016/j.kint.2018.12.025.

PMID:
31010478
3.

Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern Ontario.

Donio PJ, Freitas C, Austin PC, Ross HJ, Abdel-Qadir HM, Wijeysundera HC, Tu K, Cram P, Liu P, Abrams H, Udell JA, Mak S, Farkouh ME, Tu JV, Wang X, Tobe SW, Lee DS.

Can J Cardiol. 2019 Mar;35(3):341-351. doi: 10.1016/j.cjca.2019.01.004.

PMID:
30825954
4.

Diagnosing hypertension in Indigenous Canadians (DREAM-GLOBAL): A randomized controlled trial to compare the effectiveness of short message service messaging for management of hypertension: Main results.

Tobe SW, Yeates K, Campbell NRC, Maar MA, Perkins N, Liu PP, Sleeth J, McAllister C, Hua-Stewart D, Wells G, Bernick J.

J Clin Hypertens (Greenwich). 2019 Jan;21(1):29-36. doi: 10.1111/jch.13434. Epub 2018 Nov 26.

5.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP.

CMAJ. 2018 Oct 9;190(40):E1192-E1206. doi: 10.1503/cmaj.180194. No abstract available.

6.

What Can Declining Kidney Function Tell Us About Heart Failure?

Tobe SW.

Can J Cardiol. 2018 Oct;34(10):1261-1263. doi: 10.1016/j.cjca.2018.08.015. Epub 2018 Aug 10. No abstract available.

PMID:
30269826
7.

Sex-Specific Associations Between Alcohol Consumption and Incidence of Hypertension: A Systematic Review and Meta-Analysis of Cohort Studies.

Roerecke M, Tobe SW, Kaczorowski J, Bacon SL, Vafaei A, Hasan OSM, Krishnan RJ, Raifu AO, Rehm J.

J Am Heart Assoc. 2018 Jun 27;7(13). pii: e008202. doi: 10.1161/JAHA.117.008202. Review.

8.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
9.

Treatment of Hypertension.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Tobe SW, Gilbert RE, Jones C, Leiter LA, Prebtani APH, Woo V.

Can J Diabetes. 2018 Apr;42 Suppl 1:S186-S189. doi: 10.1016/j.jcjd.2017.10.011. No abstract available.

PMID:
29650094
10.

The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.

Ward FL, Tobe SW, Naimark DMJ.

Can J Kidney Health Dis. 2018 Mar 21;5:2054358118761051. doi: 10.1177/2054358118761051. eCollection 2018.

11.

Thresholds and Targets for Hypertension Management in Adults With Type 2 Diabetes Should Remain at 130/80 mmHg: What's the Evidence?

Shahi N, Tobe SW.

Can J Diabetes. 2018 Apr;42(2):166-172. doi: 10.1016/j.jcjd.2017.10.052. Epub 2017 Dec 20. Review.

PMID:
29273294
12.

The Effectiveness of Text Messaging for Detection and Management of Hypertension in Indigenous People in Canada: Protocol for a Randomized Controlled Trial.

Yeates K, Campbell N, Maar MA, Perkins N, Liu P, Sleeth J, Smith C, McAllister C, Hua-Stewart D, Wells G, Tobe SW.

JMIR Res Protoc. 2017 Dec 19;6(12):e244. doi: 10.2196/resprot.7139.

13.

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis.

Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J.

Lancet Public Health. 2017 Feb;2(2):e108-e120. doi: 10.1016/S2468-2667(17)30003-8. Epub 2017 Feb 7. Review.

14.

Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.

Webb DJ, Coll B, Heerspink HJL, Andress D, Pritchett Y, Brennan JJ, Houser M, Correa-Rotter R, Kohan D, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Busch R, Pergola P, Parving HH, de Zeeuw D.

Drugs R D. 2017 Sep;17(3):441-448. doi: 10.1007/s40268-017-0201-0.

15.

Changing concepts in hypertension management.

Gudsoorkar PS, Tobe SW.

J Hum Hypertens. 2017 Dec;31(12):763-767. doi: 10.1038/jhh.2017.57. Epub 2017 Jul 27. Review.

PMID:
28748919
16.

Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.

Edwards JD, Ramirez J, Callahan BL, Tobe SW, Oh P, Berezuk C, Lanctôt K, Swardfager W, Nestor S, Kiss A, Strother S, Black SE; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;59(3):1113-1122. doi: 10.3233/JAD-170238.

PMID:
28731439
17.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
18.

The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study.

Tu JV, Maclagan LC, Ko DT, Atzema CL, Booth GL, Johnston S, Tu K, Lee DS, Bierman A, Hall R, Bhatia RS, Gershon AS, Tobe SW, Sanmartin C, Liu P, Chu A; CANHEART Primary Prevention Indicator Expert Panel.

CMAJ Open. 2017 Apr 25;5(2):E315-E321. doi: 10.9778/cmajo.20160139.

19.

A Framework for the Study of Complex mHealth Interventions in Diverse Cultural Settings.

Maar MA, Yeates K, Perkins N, Boesch L, Hua-Stewart D, Liu P, Sleeth J, Tobe SW.

JMIR Mhealth Uhealth. 2017 Apr 20;5(4):e47. doi: 10.2196/mhealth.7044.

20.

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Pena MJ, de Zeeuw D, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Kohan DE, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, Sharma S, Corringham T, Sharma K, Heerspink HJL.

Diabetes Obes Metab. 2017 May;19(5):749-753. doi: 10.1111/dom.12864. Epub 2017 Feb 22.

PMID:
28019071
21.

Comparison of exposure response relationship of atrasentan between North American and Asian populations.

Heerspink HJ, Makino H, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Davis JW, Idler K, Kohan DE, Liu M, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2017 Apr;19(4):545-552. doi: 10.1111/dom.12851. Epub 2017 Jan 27.

PMID:
27981738
22.

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.

Vedanthan R, Bernabe-Ortiz A, Herasme OI, Joshi R, Lopez-Jaramillo P, Thrift AG, Webster J, Webster R, Yeates K, Gyamfi J, Ieremia M, Johnson C, Kamano JH, Lazo-Porras M, Limbani F, Liu P, McCready T, Miranda JJ, Mohan S, Ogedegbe O, Oldenburg B, Ovbiagele B, Owolabi M, Peiris D, Ponce-Lucero V, Praveen D, Pillay A, Schwalm JD, Tobe SW, Trieu K, Yusoff K, Fuster V.

Cardiol Clin. 2017 Feb;35(1):99-115. doi: 10.1016/j.ccl.2016.08.010. Review.

23.

Hypertension in Russia: Changes Observed After 4 Years of a Comprehensive Health System Improvement Program in the Yaroslavl Region.

Mozheyko M, Eregin S, Danilenko N, Vigdorchik A, Tobe SW, Campbell N, McLean D, Baskakova Z, Klimovskaia I, Ramanathan K, Hughes D.

J Clin Hypertens (Greenwich). 2017 Feb;19(2):198-204. doi: 10.1111/jch.12885. Epub 2016 Aug 17.

24.

Controversies in hypertension: is lower blood pressure always better?

Tobe SW, Izzo JL Jr.

J Am Soc Hypertens. 2016 Aug;10(8):618-20. doi: 10.1016/j.jash.2016.06.027. Epub 2016 Jun 29. No abstract available.

PMID:
27436129
25.

Hypertension in Canada: Past, Present, and Future.

Schiffrin EL, Campbell NR, Feldman RD, Kaczorowski J, Lewanczuk R, Padwal R, Tobe SW.

Ann Glob Health. 2016 Mar-Apr;82(2):288-99. doi: 10.1016/j.aogh.2016.02.006. Review.

26.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force.

Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.

PMID:
27118291
27.

Renal denervation for human hypertension: is there a future?

Izzo JL Jr, Tobe SW.

J Am Soc Hypertens. 2016 May;10(5):390-2. doi: 10.1016/j.jash.2016.02.016. Epub 2016 Mar 8.

PMID:
27049792
28.

Is there a preferred diuretic class for patients with renal impairment and hypertension?

Izzo JL Jr, Tobe SW.

J Am Soc Hypertens. 2016 Apr;10(4):282-4. doi: 10.1016/j.jash.2016.02.008. Epub 2016 Feb 23.

PMID:
26979914
29.

Age matters in the treatment and management of hypertension.

Tobe SW.

J Am Soc Hypertens. 2016 Jan;10(1):10-1. doi: 10.1016/j.jash.2015.11.004. Epub 2015 Nov 23. No abstract available.

PMID:
26850522
30.

How should BP be measured in the office?

Tobe SW, Izzo JL Jr.

J Am Soc Hypertens. 2016 Mar;10(3):189-90. doi: 10.1016/j.jash.2016.01.005. Epub 2016 Jan 11. No abstract available.

PMID:
26839184
31.

Unpacking the Black Box: A Formative Research Approach to the Development of Theory-Driven, Evidence-Based, and Culturally Safe Text Messages in Mobile Health Interventions.

Maar MA, Yeates K, Toth Z, Barron M, Boesch L, Hua-Stewart D, Liu P, Perkins N, Sleeth J, Wabano MJ, Williamson P, Tobe SW.

JMIR Mhealth Uhealth. 2016 Jan 22;4(1):e10. doi: 10.2196/mhealth.4994.

32.

Should age determine hypertension management? Recommendations from current guidelines.

Izzo JL Jr, Tobe SW.

J Am Soc Hypertens. 2016 Jan;10(1):7-9. doi: 10.1016/j.jash.2016.01.002. Epub 2016 Jan 6.

PMID:
26794655
33.

Preventing Cardiovascular and Renal Disease in Canada's Aboriginal Populations.

Tobe SW, Maar M, Roy MA, Warburton DE.

Can J Cardiol. 2015 Sep;31(9):1124-9. doi: 10.1016/j.cjca.2015.05.024. Epub 2015 Jun 5. Review.

PMID:
26321434
34.

Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy.

Kohan DE, Lambers Heerspink HJ, Coll B, Andress D, Brennan JJ, Kitzman DW, Correa-Rotter R, Makino H, Perkovic V, Hou FF, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1568-74. doi: 10.2215/CJN.00570115. Epub 2015 Jul 7.

35.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS.

Can J Cardiol. 2015 May;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016. Review.

PMID:
25936483
36.

I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions.

Maar M, Yeates K, Barron M, Hua D, Liu P, Moy Lum-Kwong M, Perkins N, Sleeth J, Tobe J, Wabano MJ, Williamson P, Tobe SW.

Implement Sci. 2015 May 4;10:64. doi: 10.1186/s13012-015-0257-6.

37.

A New Algorithm for the Diagnosis of Hypertension in Canada.

Cloutier L, Daskalopoulou SS, Padwal RS, Lamarre-Cliche M, Bolli P, McLean D, Milot A, Tobe SW, Tremblay G, McKay DW, Townsend R, Campbell N, Gelfer M.

Can J Cardiol. 2015 May;31(5):620-30. doi: 10.1016/j.cjca.2015.02.014. Epub 2015 Feb 19. Review.

38.

MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): a review & study protocol.

Blom KC, Farina S, Gomez YH, Campbell NR, Hemmelgarn BR, Cloutier L, McKay DW, Dawes M, Tobe SW, Bolli P, Gelfer M, McLean D, Bartlett G, Joseph L, Featherstone R, Schiffrin EL, Daskalopoulou SS.

Curr Hypertens Rep. 2015 Apr;17(4):533. doi: 10.1007/s11906-015-0533-5.

PMID:
25790798
39.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update.

Tobe SW, Stone JA, Walker KM, Anderson T, Bhattacharyya O, Cheng AY, Gregoire J, Gubitz G, L'Abbé M, Lau DC, Leiter LA, Oh P, Padwal R, Poirier L, Selby P, Tremblay M, Ward RA, Hua D, Liu PP; C-CHANGE Initiative.

CMAJ. 2014 Nov 18;186(17):1299-305. doi: 10.1503/cmaj.140387. Epub 2014 Oct 20. No abstract available.

40.

Intraclass differences among antihypertensive drugs.

Feldman RD, Hussain Y, Kuyper LM, McAlister FA, Padwal RS, Tobe SW.

Annu Rev Pharmacol Toxicol. 2015;55:333-52. doi: 10.1146/annurev-pharmtox-010814-124446. Epub 2014 Sep 22. Review.

PMID:
25251994
41.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

42.

β-Blockers in hypertension: studies and meta-analyses over the years.

Larochelle P, Tobe SW, Lacourcière Y.

Can J Cardiol. 2014 May;30(5 Suppl):S16-22. doi: 10.1016/j.cjca.2014.02.012. Epub 2014 Feb 25. Review.

43.

β-adrenergic receptor blockers in hypertension.

Tobe SW.

Can J Cardiol. 2014 May;30(5 Suppl):S1-2. doi: 10.1016/j.cjca.2014.02.015. Epub 2014 Feb 26. Review. No abstract available.

44.

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.

de Zeeuw D, Coll B, Andress D, Brennan JJ, Tang H, Houser M, Correa-Rotter R, Kohan D, Lambers Heerspink HJ, Makino H, Perkovic V, Pritchett Y, Remuzzi G, Tobe SW, Toto R, Viberti G, Parving HH.

J Am Soc Nephrol. 2014 May;25(5):1083-93. doi: 10.1681/ASN.2013080830. Epub 2014 Apr 10.

45.

Contemporary use of β-blockers: clinical relevance of subclassification.

Poirier L, Tobe SW.

Can J Cardiol. 2014 May;30(5 Suppl):S9-S15. doi: 10.1016/j.cjca.2013.12.001. Epub 2013 Dec 4. Review.

46.

A Canadian perspective on the Eighth Joint National Committee (JNC 8) hypertension guidelines.

Myers MG, Tobe SW.

J Clin Hypertens (Greenwich). 2014 Apr;16(4):246-8. doi: 10.1111/jch.12307. Epub 2014 Mar 19. No abstract available.

47.

Healthy food procurement policies and their impact.

Niebylski ML, Lu T, Campbell NR, Arcand J, Schermel A, Hua D, Yeates KE, Tobe SW, Twohig PA, L'Abbé MR, Liu PP.

Int J Environ Res Public Health. 2014 Mar 3;11(3):2608-27. doi: 10.3390/ijerph110302608. Review.

48.

Combining other antihypertensive drugs with β-blockers in hypertension: a focus on safety and tolerability.

Richards TR, Tobe SW.

Can J Cardiol. 2014 May;30(5 Suppl):S42-6. doi: 10.1016/j.cjca.2013.08.012. Epub 2014 Feb 8. Review.

49.

Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.

Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2014 Jan;30(1):16-21. doi: 10.1016/j.cjca.2013.07.008. Epub 2013 Oct 23. Review.

PMID:
24269056
50.

Hypertension analysis of stress reduction using mindfulness meditation and yoga: results from the HARMONY randomized controlled trial.

Blom K, Baker B, How M, Dai M, Irvine J, Abbey S, Abramson BL, Myers MG, Kiss A, Perkins NJ, Tobe SW.

Am J Hypertens. 2014 Jan;27(1):122-9. doi: 10.1093/ajh/hpt134. Epub 2013 Sep 14.

PMID:
24038797

Supplemental Content

Support Center